M02.36

Clinical Causes: Infection in the body, usually bacterial, such as Chlamydia trachomatis, Salmonella, Shigella, Yersinia, or Campylobacter. The body's immune response to these infections, which can cause inflammation in the joints, tendons, and other areas. Genetic predisposition, with certain genes like HLA-B27 increasing the risk. Environmental factors, such as stress or injury, may exacerbate symptoms or trigger flare-ups.

Key Symptoms: Joint pain, swelling, and stiffness, especially in the knees, ankles, and feet. Pain that worsens with activity and improves with rest. Conjunctivitis (redness and irritation of the eyes). Urinary tract symptoms, such as discomfort during urination or unusual discharge. Skin changes, including rashes or lesions on the skin, particularly on the soles of the feet or palms. Low-grade fever and fatigue.

Diagnosis Path: Diagnosing Reiter's disease involves a combination of medical history, physical examination, and laboratory tests. The healthcare provider may look for signs of joint swelling, eye irritation, and urinary symptoms. Blood tests might include tests for signs of inflammation, bacterial infections, and genetic markers like HLA-B27. Imaging studies such as X-rays can help evaluate joint damage or inflammation, but they are not definitive. There are no specific tests exclusive to Reiter's disease, so diagnosis often depends on identifying characteristic patterns and ruling out other conditions.

Treatment Protocols: Management of Reiter's disease focuses on relieving symptoms and addressing underlying infections when possible. Treatment options include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. - Corticosteroids, either oral or injectable, for more severe inflammation. - Antibiotics if an ongoing bacterial infection is identified. - Physical therapy to maintain joint function and strength. - Rest and activity modification to lessen joint stress. - Addressing any associated conditions, such as eye inflammation or skin lesions. In some cases, disease-modifying antirheumatic drugs (DMARDs) may be prescribed for persistent or severe symptoms. Regular follow-up with healthcare providers is important to monitor the condition and adjust treatments as necessary.